QL Biopharma
Changping
About QL Biopharma
QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $129.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Mar 2026)
- Website: qlbiopharm.com
- Phone: 010-6170-2599
Industries & Categories
Biopharma, Health Care, Medical
Canonical: https://fsome.com/organization/ql-biopharma-26147 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.